医学研究生学报
醫學研究生學報
의학연구생학보
JOURNAL OF MEDICAL POSTGRADUATE
2015年
8期
847-849
,共3页
游云鹏%郑大东%王颖%钟勇%潘士勇
遊雲鵬%鄭大東%王穎%鐘勇%潘士勇
유운붕%정대동%왕영%종용%반사용
左卡尼汀%非酒精性脂肪肝%疗效
左卡尼汀%非酒精性脂肪肝%療效
좌잡니정%비주정성지방간%료효
Levocarnitine%Non-alcoholic fatty liver%Clinical efficacy
目的:非酒精性脂肪肝( Nonalcoholic fatty liver , NAFL)是一种代谢性疾病,左卡尼汀具有改善机体代谢作用。文章旨在观察左卡尼汀治疗NAFL的疗效。方法回顾性收集2012年1月至2013年6月期间南京军区南京总医院门诊85例NAFL患者,并根据治疗方法的不同分为左卡尼汀组和对照组。左卡尼汀组( n=45)在生活方式干预的基础上应用左卡尼汀治疗4周,减量后继续治疗8周;对照组( n=40)仅给予生活方式干预。结果左卡尼汀治疗12周后,左卡尼汀组显效37例,无效8例,有效率82.2%;对照组显效25例,无效15例,有效率50.0%。2组有效率比较差异有统计学意义( P<0.01)。左卡尼汀组在治疗过程中未发生不良反应。结论在生活方式干预基础上应用左卡尼汀治疗非酒精性脂肪肝可提高治疗有效率。
目的:非酒精性脂肪肝( Nonalcoholic fatty liver , NAFL)是一種代謝性疾病,左卡尼汀具有改善機體代謝作用。文章旨在觀察左卡尼汀治療NAFL的療效。方法迴顧性收集2012年1月至2013年6月期間南京軍區南京總醫院門診85例NAFL患者,併根據治療方法的不同分為左卡尼汀組和對照組。左卡尼汀組( n=45)在生活方式榦預的基礎上應用左卡尼汀治療4週,減量後繼續治療8週;對照組( n=40)僅給予生活方式榦預。結果左卡尼汀治療12週後,左卡尼汀組顯效37例,無效8例,有效率82.2%;對照組顯效25例,無效15例,有效率50.0%。2組有效率比較差異有統計學意義( P<0.01)。左卡尼汀組在治療過程中未髮生不良反應。結論在生活方式榦預基礎上應用左卡尼汀治療非酒精性脂肪肝可提高治療有效率。
목적:비주정성지방간( Nonalcoholic fatty liver , NAFL)시일충대사성질병,좌잡니정구유개선궤체대사작용。문장지재관찰좌잡니정치료NAFL적료효。방법회고성수집2012년1월지2013년6월기간남경군구남경총의원문진85례NAFL환자,병근거치료방법적불동분위좌잡니정조화대조조。좌잡니정조( n=45)재생활방식간예적기출상응용좌잡니정치료4주,감량후계속치료8주;대조조( n=40)부급여생활방식간예。결과좌잡니정치료12주후,좌잡니정조현효37례,무효8례,유효솔82.2%;대조조현효25례,무효15례,유효솔50.0%。2조유효솔비교차이유통계학의의( P<0.01)。좌잡니정조재치료과정중미발생불량반응。결론재생활방식간예기출상응용좌잡니정치료비주정성지방간가제고치료유효솔。
Objective Non-alcoholic fatty liver ( NAFL) is a metabolic disease and levocarnitine can be used to improve the energy metabolism of the patient .This study aimed to evaluate the clinical efficacy of levocarnitine in the treatment of NAFL . Methods We retrospectively analyzed 85 cases of NAFL treated by lifestyle intervention (control group, n=40) or by lifestyle intervention +levo-carnitine medication (medication group, n=45).In addition to lifestyle intervention, the patients in the medication group received oral levocarnitine at 10 mL tid for 4 weeks followed by a reduced dose of 10 mL bid for another 8 weeks. Results Twelve weeks after treat-ment, 37 cases (82.2%) in the medication group showed remarkable improvement and the other 8 failed to respond.In the control group, 23 cases (57.5%) were improved and 17 cases remained unimproved .There were statistically significant differences in the rate of therapeutic effectiveness between the two groups of patients (P<0.01).No adverse effects were observed during the levocarnitine medi-cation. Conclusion Lifestyle intervention +levocarnitine medication can improve NAFL .